SEC Comment Letter 0000000000-23-001477 to Black Bird Biotech, Inc. (BBBT) (CIK 0001409999)
Black Bird Biotech, Inc. (BBBT) (CIK 0001409999)
Date: Feb. 13, 2023 · CIK: 0001409999 · Accession: 0000000000-23-001477
AI Filing Summary & Sentiment
File numbers found in text: 333-269630
Letter
United States securities and exchange commission logo February 13, 2023 Fabian Deneault President Black Bird Biotech, Inc. 11961 Hilltop Road, Suite 22 Argyle, Texas 76226 Re:Black Bird Biotech, Inc. Registration Statement on Form S-1 Filed February 7, 2023 File No. 333-269630 Dear Fabian Deneault: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Gregory Herbers at 202-551-8028 with any questions. Sincerely, Division of Corporation Finance Office of Manufacturing cc: Eric J. Newlan, Esq.
Show Raw Text
United States securities and exchange commission logo
February 13, 2023
Fabian Deneault
President
Black Bird Biotech, Inc.
11961 Hilltop Road, Suite 22
Argyle, Texas 76226
Re:Black Bird Biotech, Inc.
Registration Statement on Form S-1
Filed February 7, 2023
File No. 333-269630
Dear Fabian Deneault:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Gregory Herbers at 202-551-8028 with any questions.
Sincerely,
Division of Corporation Finance
Office of Manufacturing
cc: Eric J. Newlan, Esq.